Patrick Delarive Overview

  • Investor Type
  • Angel
  • Investments
  • 1
  • Portfolio
  • 1

Patrick Delarive General Information


Mr. Patrick Delarive serves as Funding Partner & Board Member at BioWatch. He is also the Founder and serves as President at Delarive Groupe. Mr. Delarive advises executives of major companies and politicians in Switzerland and abroad on change related to generational, economic and technological changes, particularly as a professional speaker. Patrick is an entrepreneur whose curiosity and ambition are matched only by the desire to innovate.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • Route de la Corniche 5
  • C/o StartLab Secteur Esplanade - Bâtiment SE-B
  • 1066 Epalinges
  • Switzerland

Patrick Delarive Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00000000 19-Jan-2017 0000 00000 00.000 Wireless Communications Equipment Generating Revenue 0000000 00000000
To view Patrick Delarive’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Patrick Delarive Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Patrick Delarive Team (1)

Name Title Deals Funds Boards Office
Patrick Delarive Angel Investor 0 0 Epalinges, Switzerland
To view Patrick Delarive’s complete team members history, request access »

Patrick Delarive Co-Investors (3)

Name With Exits Lead Partner Series Industry
Fusion partners (Switzerland) 1 0 Series chart Industry bar
PolyTech Ventures 0 0 Series chart Industry bar
SICPA Holdings 0 0 Series chart Industry bar
To view Patrick Delarive’s complete co-investors history, request access »